首頁 > 市場調查報告書 > 醫療設備

e保健體外診斷藥物開發人工智能人工智能藥物研發診斷用人工智能

市場調查報告書

商品編碼

1824584

2025年生命科學領域人工智慧全球市場報告

Artificial Intelligence In Life Sciences Global Market Report 2025

出版日期: 2025年09月10日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年，生命科學領域的人工智慧市場將呈指數級成長，到2029年將達到84.2億美元，複合年成長率為23.7%。預測期內的成長可歸因於人們對即時遠端患者監護(RPM) 系統日益成長的興趣、藥物研發領域對人工智慧的需求不斷成長，以及醫學影像分析領域對人工智慧的採用日益增多。預測期內的主要趨勢包括策略夥伴關係、產品創新、技術進步、投資和研發。

未來五年23.7%的成長率預測較先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致美國和瑞士開發的人工智慧（AI）主導的基因組定序分析儀和藥物交互作用預測平台的價格上漲，阻礙英國生物醫學研究，延緩科學突破並增加研發支出。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，貿易摩擦的影響可能更為廣泛。

人們對即時遠端患者監護(RPM) 系統日益成長的興趣可能會在短期內推動人工智慧在生命科學市場的擴張。遠端患者監護系統採用科技主導的醫療保健解決方案，旨在超越傳統醫療環境監控病人健康狀況。在生命科學領域，人工智慧在遠端患者監護中發揮關鍵作用，透過提供持續、個人化和數據主導的洞察，促進主動醫療管理。美國數位醫療保健公司 Vivalink 進行的一項調查顯示，臨床醫生對遠端患者監護(RPM) 的採用率顯著上升，從 2021 年的 20% 成長到 2022 年的 81%，增幅高達 305%。因此，人們對即時遠端患者監護(RPM) 系統日益成長的興趣正在推動生命科學市場人工智慧的成長。

全球生命科學人工智慧：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
最終用途產業分析
全球生命科學人工智慧市場：成長率分析
全球生命科學人工智慧市場表現：規模與成長，2019-2024
全球生命科學人工智慧市場預測：規模與成長，2024-2029 年，2034 年預測
全球生命科學領域的人工智慧：總潛在市場（TAM）

第6章市場細分

全球生命科學領域人工智慧市場：依產品、現況及預測，2019-2024 年、2024-2029 年、2034 年
軟體
硬體
服務
全球生命科學領域人工智慧市場：部署、表現與預測（2019-2024 年、2024-2029 年及 2034 年）
本地部署
雲端基礎
全球生命科學領域人工智慧市場：應用、表現與預測（2019-2024 年、2024-2029 年及 2034 年）
藥物研發
醫療診斷
生物技術
臨床試驗
精準醫療與個人化醫療
病患監測
全球生命科學人工智慧市場：依軟體類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
藥物研發軟體
基因組分析軟體
臨床試驗管理軟體
個人化醫療軟體
實驗室資訊管理系統（LIMS）
全球生命科學領域人工智慧市場：按硬體（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
人工智慧實驗室設備
機器人和自動化系統
影像設備和裝置
感測器技術
全球生命科學領域人工智慧市場：按服務類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
諮詢服務
數據分析服務
研發服務
實施和整合服務
培訓和支援服務

第7章區域和國家分析

全球生命科學人工智慧市場：區域分析、預測與成長，2019-2024 年、2024-2029 年、2034 年
全球生命科學領域人工智慧市場：各國發展、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

生命科學領域的人工智慧：競爭格局
生命科學市場中的人工智慧：公司簡介
- Google LLC Overview, Products and Services, Strategy and Financial Analysis
- Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
- IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

Nvidia Corporation
Novo Nordisk A/S
Siemens Healthineers AG
Philips Healthcare
Babylon Healthcare Services Ltd.
Komodo Health Inc.
Modernizing Medicine Inc.
Viz.ai Inc.
Butterfly Network Inc.
Augmedix
AiCure LLC
HealthTap Inc.
Welltok Inc.
Enlitic Inc.
PathAI Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029年生命科學市場中的人工智慧：提供新機會的國家
2029年生命科學市場人工智慧：細分領域帶來新機會
2029年生命科學市場人工智慧：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r27399u

Artificial intelligence (AI) in life sciences involves the application of AI technologies and techniques across various domains within the life sciences industry. The integration of AI aims to enhance and expedite processes, improve decision-making, and extract valuable insights from complex data sets.

The primary components of artificial intelligence in life sciences include software, hardware, and services. The software employs AI algorithms to analyze extensive chemical databases, predicting the likelihood of specific molecules binding to target receptors, thereby accelerating the drug discovery process. These software applications can be deployed through on-premises and cloud-based models and find applications in various domains such as drug discovery, medical diagnosis, biotechnology, clinical trials, precision and personalized medicine, and patient monitoring.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The artificial intelligence in life sciences market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in life sciences market statistics, including artificial intelligence in life sciences industry global market size, regional shares, competitors with artificial intelligence in life sciences market share, detailed artificial intelligence in life science market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence in life sciences industry. This artificial intelligence in life sciences market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.2%. The growth in the historic period can be attributed to increasing number of clinical trials, increasing adoption of ai in the domain of research and development, high emphasis on the development of precision medicine and personalized drugs.

The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to the increasing interest in real-time remote patient monitoring (rpm) systems, increasing demand for AI in drug discovery, the increasing adoption of ai in medical imaging analysis. Major trends in the forecast period include strategic partnership, product innovations, technological advancements, investments, research and developments.

The forecast of 23.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biomedical research by inflating prices of Artificial intelligence(AI)-driven genomic sequencing analyzers and drug interaction prediction platforms developed in the UK and Switzerland, resulting in slower scientific breakthroughs and higher Research and Developemnet (R&D) expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing interest in real-time remote patient monitoring (RPM) systems is set to drive the expansion of artificial intelligence in the life sciences market in the foreseeable future. Remote patient monitoring systems, characterized by technology-driven healthcare solutions, aim to monitor patients' health beyond traditional healthcare settings. In the life sciences domain, AI plays a pivotal role in remote patient monitoring, offering continuous, personalized, and data-driven insights that facilitate proactive healthcare management. A survey conducted by Vivalink, a US-based digital healthcare company, revealed a noteworthy surge in clinicians' adoption of remote patient monitoring (RPM), growing from 20% in 2021 to 81% in 2022, representing a substantial 305% increase. Consequently, the rising interest in real-time remote patient monitoring (RPM) systems is steering the growth of artificial intelligence in the life sciences market.

Leading companies operating in the artificial intelligence in the life sciences market are directing their efforts towards innovative products featuring technological advancements, exemplified by drug discovery software, to maintain their market standing. Drug discovery software comprises computer programs and applications tailored to assist researchers in the pharmaceutical and biotechnology sectors during the drug discovery process. In December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a revolutionary drug discovery software. Positioned as the first of its kind, AIDDISON integrates virtual molecule design with real-world manufacturability, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON excels in identifying drug candidates from a vast array of possibilities, considering essential properties such as non-toxicity and solubility. Its unique capability to bridge the gap between virtual molecule design and real-world manufacturability underscores a notable application of artificial intelligence in the life sciences sector.

In June 2023, Verix, a US-based company specializing in pharma commercial operations, completed the acquisition of Start-up.AI for an undisclosed sum. Verix's strategic move to acquire Start-up.AI aims to fortify its capabilities in artificial intelligence (AI) and machine learning (ML) within the pharmaceutical commercial operations sector. Start-up.ai, based in Israel, is a provider of an AI-driven commercial optimization platform, enhancing Verix's prowess in life science AI capabilities.

Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in the life sciences market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in the life sciences market consists of revenues earned by entities by private analytics, AI-driven clinical trial services, and real-world evidence services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the life sciences market also consists of sales of high-performance computing (HPC) clusters, edge computing devices, and IoT devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Life Sciences Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in life sciences market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in life sciences ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in life sciences market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Offering: Software; Hardware; Services
2) By Deployment: On-Premises; Cloud-Based
3) By Application: Drug Discovery; Medical Diagnosis; Biotechnology; Clinical Trails; Precision And Personalized Medicine; Patient Monitoring
Subsegments:
1) By Software: Drug Discovery Software; Genomic Analysis Software; Clinical Trial Management Software; Personalized Medicine Software; Laboratory Information Management Systems (LIMS)
2) By Hardware: AI-Enabled Laboratory Equipment; Robotics And Automation Systems; Imaging Devices And Equipment; Sensor Technologies
3) By Services: Consulting Services; Data Analytics Services; Research And Development Services; Implementation And Integration Services; Training And Support Services
Companies Mentioned: Google LLC; Microsoft Corporation; Intel Corporation; IBM Corporation; Medtronic PLC; Nvidia Corporation; Novo Nordisk A/S; Siemens Healthineers AG; Philips Healthcare; Babylon Healthcare Services Ltd.; Komodo Health Inc.; Modernizing Medicine Inc.; Viz.ai Inc.; Butterfly Network Inc.; Augmedix; AiCure LLC; HealthTap Inc.; Welltok Inc.; Enlitic Inc.; PathAI Inc.; Nano-X Imaging Ltd.; Berg LLC; Insitro; Sense.ly Inc.; Subtle Medical Inc.; Medasense Biometrics Limited; Immunai; Atomwise Inc.; Freenome Holdings Inc.; CloudMedX Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Artificial Intelligence In Life Sciences Market Characteristics

3. Artificial Intelligence In Life Sciences Market Trends And Strategies

4. Artificial Intelligence In Life Sciences Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Life Sciences Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence In Life Sciences PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artificial Intelligence In Life Sciences Market Growth Rate Analysis
5.4. Global Artificial Intelligence In Life Sciences Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artificial Intelligence In Life Sciences Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artificial Intelligence In Life Sciences Total Addressable Market (TAM)

6. Artificial Intelligence In Life Sciences Market Segmentation

6.1. Global Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Hardware
Services
6.2. Global Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
On-Premises
Cloud-Based
6.3. Global Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery
Medical Diagnosis
Biotechnology
Clinical Trials
Precision And Personalized Medicine
Patient Monitoring
6.4. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery Software
Genomic Analysis Software
Clinical Trial Management Software
Personalized Medicine Software
Laboratory Information Management Systems (LIMS)
6.5. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
AI-Enabled Laboratory Equipment
Robotics And Automation Systems
Imaging Devices And Equipment
Sensor Technologies
6.6. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Data Analytics Services
Research And Development Services
Implementation And Integration Services
Training And Support Services

7. Artificial Intelligence In Life Sciences Market Regional And Country Analysis

7.1. Global Artificial Intelligence In Life Sciences Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Intelligence In Life Sciences Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Life Sciences Market

8.1. Asia-Pacific Artificial Intelligence In Life Sciences Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Life Sciences Market

9.1. China Artificial Intelligence In Life Sciences Market Overview
9.2. China Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Life Sciences Market

10.1. India Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Life Sciences Market

11.1. Japan Artificial Intelligence In Life Sciences Market Overview
11.2. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Life Sciences Market

12.1. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Life Sciences Market

13.1. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Life Sciences Market

14.1. South Korea Artificial Intelligence In Life Sciences Market Overview
14.2. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Life Sciences Market

15.1. Western Europe Artificial Intelligence In Life Sciences Market Overview
15.2. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Life Sciences Market

16.1. UK Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Life Sciences Market

17.1. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Life Sciences Market

18.1. France Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Life Sciences Market

19.1. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Life Sciences Market

20.1. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Life Sciences Market

21.1. Eastern Europe Artificial Intelligence In Life Sciences Market Overview
21.2. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Life Sciences Market

22.1. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Life Sciences Market

23.1. North America Artificial Intelligence In Life Sciences Market Overview
23.2. North America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Life Sciences Market

24.1. USA Artificial Intelligence In Life Sciences Market Overview
24.2. USA Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Life Sciences Market

25.1. Canada Artificial Intelligence In Life Sciences Market Overview
25.2. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Life Sciences Market

26.1. South America Artificial Intelligence In Life Sciences Market Overview
26.2. South America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Life Sciences Market

27.1. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Life Sciences Market

28.1. Middle East Artificial Intelligence In Life Sciences Market Overview
28.2. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Life Sciences Market

29.1. Africa Artificial Intelligence In Life Sciences Market Overview
29.2. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Life Sciences Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence In Life Sciences Market Competitive Landscape
30.2. Artificial Intelligence In Life Sciences Market Company Profiles
- 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Life Sciences Market Other Major And Innovative Companies

31.1. Nvidia Corporation
31.2. Novo Nordisk A/S
31.3. Siemens Healthineers AG
31.4. Philips Healthcare
31.5. Babylon Healthcare Services Ltd.
31.6. Komodo Health Inc.
31.7. Modernizing Medicine Inc.
31.8. Viz.ai Inc.
31.9. Butterfly Network Inc.
31.10. Augmedix
31.11. AiCure LLC
31.12. HealthTap Inc.
31.13. Welltok Inc.
31.14. Enlitic Inc.
31.15. PathAI Inc.

32. Global Artificial Intelligence In Life Sciences Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Life Sciences Market

34. Recent Developments In The Artificial Intelligence In Life Sciences Market

35. Artificial Intelligence In Life Sciences Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence In Life Sciences Market In 2029 - Countries Offering Most New Opportunities
35.2 Artificial Intelligence In Life Sciences Market In 2029 - Segments Offering Most New Opportunities
35.3 Artificial Intelligence In Life Sciences Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies